Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.69)
# 748
Out of 5,063 analysts
464
Total ratings
41.58%
Success rate
9.38%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $6.09 | +228.41% | 4 | Nov 19, 2025 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | $4 → $6 | $3.87 | +55.04% | 16 | Nov 18, 2025 | |
| LFWD Lifeward | Maintains: Buy | $13 → $4.5 | $0.52 | +765.38% | 8 | Nov 18, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $130 → $155 | $108.01 | +43.51% | 5 | Nov 17, 2025 | |
| CELC Celcuity | Downgrades: Neutral | $77 → $94 | $94.00 | - | 11 | Nov 17, 2025 | |
| PGEN Precigen | Maintains: Buy | $8.5 → $9 | $3.90 | +130.77% | 14 | Nov 14, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $55 → $32 | $6.86 | +366.47% | 16 | Nov 14, 2025 | |
| PSNL Personalis | Maintains: Buy | $10 → $13 | $8.28 | +57.00% | 19 | Nov 11, 2025 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $40 → $47 | $40.39 | +16.37% | 8 | Nov 10, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $3.5 → $5 | $3.70 | +35.14% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $81 | $69.16 | +17.12% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $2.5 | $0.31 | +711.69% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.83 | +173.22% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $5.27 | +317.46% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.93 | +224.29% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $30 | $8.19 | +266.30% | 15 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $145 | $75.05 | +93.20% | 24 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $5.34 | +199.63% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.14 | +414.02% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.53 | +10.38% | 10 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $3.57 | +320.17% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.12 | +167.86% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.11 | +530.63% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $16.30 | +114.72% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $16.86 | +83.87% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.24 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.78 | +285.41% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.36 | +47.06% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.38 | +153.62% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.36 | +705.08% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.77 | +152.71% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.59 | +11,220.75% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.62 | +441.13% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $28.59 | +144.84% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $37.85 | +58.52% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $6.17 | +434.85% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.38 | +1,215.79% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.05 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.54 | +68.20% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.16 | +532.91% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.46 | +101.79% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.55 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.57 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.74 | +417.24% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.71 | +1,361.99% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.80 | +177.78% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.82 | +4,155.32% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.20 | +900.00% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $1.16 | +1,624.14% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.66 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $8.51 | -29.49% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.49 | +906.71% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $9.81 | +236.39% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $19.61 | -51.56% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.04 | +1,346,053.85% | 1 | Mar 5, 2020 |
Actuate Therapeutics
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $6.09
Upside: +228.41%
Ekso Bionics Holdings
Nov 18, 2025
Maintains: Buy
Price Target: $4 → $6
Current: $3.87
Upside: +55.04%
Lifeward
Nov 18, 2025
Maintains: Buy
Price Target: $13 → $4.5
Current: $0.52
Upside: +765.38%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $108.01
Upside: +43.51%
Celcuity
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $94.00
Upside: -
Precigen
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.90
Upside: +130.77%
Vor Biopharma
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $6.86
Upside: +366.47%
Personalis
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $8.28
Upside: +57.00%
Dianthus Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $40.39
Upside: +16.37%
X4 Pharmaceuticals
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.70
Upside: +35.14%
Nov 5, 2025
Maintains: Buy
Price Target: $80 → $81
Current: $69.16
Upside: +17.12%
Nov 4, 2025
Assumes: Buy
Price Target: $2.5
Current: $0.31
Upside: +711.69%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.83
Upside: +173.22%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $5.27
Upside: +317.46%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.93
Upside: +224.29%
Oct 20, 2025
Maintains: Buy
Price Target: $31 → $30
Current: $8.19
Upside: +266.30%
Oct 20, 2025
Reiterates: Buy
Price Target: $145
Current: $75.05
Upside: +93.20%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $5.34
Upside: +199.63%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.14
Upside: +414.02%
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $4.53
Upside: +10.38%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $3.57
Upside: +320.17%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.12
Upside: +167.86%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.11
Upside: +530.63%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $16.30
Upside: +114.72%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $16.86
Upside: +83.87%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.24
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.78
Upside: +285.41%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.36
Upside: +47.06%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.38
Upside: +153.62%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.36
Upside: +705.08%
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $2.77
Upside: +152.71%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.59
Upside: +11,220.75%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.62
Upside: +441.13%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $28.59
Upside: +144.84%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $37.85
Upside: +58.52%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $6.17
Upside: +434.85%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.38
Upside: +1,215.79%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.05
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.54
Upside: +68.20%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $3.16
Upside: +532.91%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $4.46
Upside: +101.79%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.55
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.57
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.74
Upside: +417.24%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.71
Upside: +1,361.99%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.80
Upside: +177.78%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.82
Upside: +4,155.32%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.20
Upside: +900.00%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $1.16
Upside: +1,624.14%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $12.66
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $8.51
Upside: -29.49%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.49
Upside: +906.71%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $9.81
Upside: +236.39%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $19.61
Upside: -51.56%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.04
Upside: +1,346,053.85%